The types segment classifies zirconia implant materials by their microstructural composition, principally into monolithic zirconia (3Y‑TZP) and high‑translucency zirconia (5Y‑TZP) variants. Monolithic zirconia, containing approximately 3 % yttria, offers superior flexural strength and is favored for load‑bearing sites, contributing a substantial portion of the market despite a modest price premium. High‑translucency zirconia, stabilized with 5 % yttria, provides enhanced esthetic performance at the expense of reduced fracture toughness, capturing demand in anterior regions where visual integration is critical. A secondary sub‑type, zirconia‑toughened alumina (ZTA), combines alumina’s hardness with zirconia’s transformation toughening, addressing niche applications that require both wear resistance and moderate strength. The distribution of these material types aligns with clinical decision‑making criteria—strength versus esthetics—thereby influencing overall market size through differentiated pricing, adoption rates, and R&D investment.